| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 11,707 | 10,556 | 10,688 | 4,881 | | Cost of Revenue | 5,895 | 2,367 | 2,011 | (14,418) | | | Gross Profit | 5,812 | 8,189 | 8,678 | 19,299 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,273 | 4,620 | 3,976 | 17,426 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 4,560 | 4,229 | 4,124 | 494 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (21) | (660) | 578 | 1,379 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (574) | (508) | (468) | (2,246) | | Earnings Before Interest And Taxes | (595) | (1,168) | 110 | (2,307) | | Interest Expense | 3,074 | 2,832 | 2,753 | 611 | | Income Before Tax | (3,669) | (4,001) | (2,644) | (2,919) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest | 228 | 32 |
-
| (1,441) | | | | Net Income From Continuing Ops | (3,701) | (3,969) | (2,644) | (2,919) | | | Non-recurring Events | | Discontinued Operations | 301 | 239 |
-
| (1) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (3,141) | (3,730) | (2,644) | (2,920) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,543) | ($3,730) | ($2,644) | ($2,920) |
|
0.03% Nasdaq 0.00%
Income Statement
